Concepedia

Prafulla Girase

PG

6

Publications

181

Citations

6

H-Index

2005

Active since

Affiliations

Pfizer (United States)(Current)

IQVIA (United States)

Cornell University

Prafulla Girase is an author at Pfizer (United States) specializing in antibiotics, antimicrobial pharmacokinetics, and health policy.

Top concepts

Publications per year

2005–2012

6

Publications

6

Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti‐diabetic medication: a follow‐up study

Madé Wenten, J. A. Gaebler, Mohamed Hussein et al. · Diabetic Medicine · 2012 · 75 citations · Full text

Determining initial and follow-up costs of cardiovascular events in a US managed care population

Richard H. Chapman, Larry Z. Liu, Prafulla Girase et al. · BMC Cardiovascular Disorders · 2011 · 30 citations · Full text

Economic impact of extended-release tolterodine versus immediate- and extended-release oxybutynin among commercially insured persons with overactive bladder.

S Varadharajan, Zhanna Jumadilova, Prafulla Girase et al. · PubMed · 2005 · 27 citations

Generic and therapeutic statin switches and disruptions in therapy

Richard H. Chapman, Joshua S. Benner, Prafulla Girase et al. · Current Medical Research and Opinion · 2009 · 23 citations

The economic effect of oral linezolid versus intravenous vancomycin in the outpatient setting: the payer perspective.

Peggy S. McKinnon, Chureen T. Carter, Prafulla Girase et al. · PubMed · 2007 · 16 citations

, , +21

Rows per page

1–5 of 6